| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615274 | Clinical Lymphoma Myeloma and Leukemia | 2018 | 16 Pages |
Abstract
Entospletinib monotherapy at 800 mg twice daily demonstrated limited activity in patients with advanced, relapsed DLBCL.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
John M. Burke, Andrei Shustov, James Essell, Dipti Patel-Donnelly, Jay Yang, Robert Chen, Wei Ye, Wen Shi, Sarit Assouline, Jeff Sharman,